Overexpression of p16INK4A and p14ARF in haematological malignancies

Clinical and Laboratory Haematology

Volumn 25, Issue 4, 2003, Pages 233-237

  Lee, Young Kyung ^a,b   Park, J Y ^a   Kang, H J ^a   Cho, H C ^a  

^a Hallym University College of Medicine   (South Korea)

^b Hallym University Sacred Heart Hospital   (South Korea)

Author keywords

Chronic myelogenous leukaemia; Haematological malignancy; p14ARF; p16INK4A; Tumour suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P14 INK4A; PROTEIN P16 ARF; UNCLASSIFIED DRUG; PROTEIN P14ARF; PROTEIN P16INK4A; RNA; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BIOASSAY; BONE MARROW; CANCER INHIBITION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENE OVEREXPRESSION; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERPLASIA; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; BIOSYNTHESIS; BLOOD DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR SUPPRESSOR GENE;

BONE MARROW; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0043161789     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2003.00520.x     Document Type: Article

References (21)

1. Beck Z., Kiss A., Toth F.D., Szabo J., Bacsi A., Balogh E., Borbely A., Telek B., Kovacs E., Olah E. & Rak K. (2000) Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia. Leukemia and Lymphoma 38, 587-597.
2. Chomczynski P. & Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-159.
3. Clurman B.E. & Croudine M. (1998) The CDKN2A tumor-suppressor locus - a tale of two proteins. The New England Journal of Medicine 338, 910-912.
4. Di Bacco A., Keeshan K., McKenna S.L. & Cotter T.G. (2000) Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. The Oncologist 5, 405-415.
5. ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood 91, 1016-1020.
6. Gorgoulis V.G., Zacharatos P., Kotsinas A., Liloglou T., Kyroudi A., Veslemes M., Rassidakis A., Halazonetis T.D., Field J.K. & Kittas C. (1998) Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. American Journal of Pathology 153, 1749-1765.
7. CDKN2 expression and its implications for cell immortalization and senescence. Molecular and Cellular Biology 16, 859-867.
8. Hussussian C.J., Struewing J.P., Goldstein A.M., Higgins P.A., Ally D.S., Sheahan M.D., Clark W.H., Jr. Tucker M.A. & Dracopoli N.C. (1994) Germline p16 mutations in familial melanoma. Nature Genetics 8, 15-21.
9. ARF tumor suppressor in acute myeloid leukemia. Nature Medicine 8, 743-750.
10. INK4A transcript. Cancer Research 55, 2995-2997.
11. INK4 in human cancer. Proceedings of the National Academy of Sciences of the USA 91, 11045-11049.
12. ARF links the tumour suppressor p53 to Ras. Nature 395, 125-126.
13. Quelle D.E., Zindy F., Ashmun R.A. & Sherr C.J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
14. Quesnel B., Preudhomme C., Philippe N., Vanrumbeke M., Dervite I., Lai J.L., Bauters F., Wattel E. & Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85, 657-663.
15. INK4a/CDKN2A tumor suppressor and its relatives. Biochimica et Biophysica Acta 1378, F115-F177.
16. Sherr C.J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes & Development 12, 2984-2991.
17. Sill H., Goldman J.M. & Cross N.C. (1995) Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85, 2013-2016.
18. ARF, participates in a regulatory feedback loop with p53 and MDM2. The EMBO Journal 17, 5001-5014.
19. ARF in hematological malignancies. Leukemia 13, 1760-1769.
20. ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes. Leukemia and Lymphoma 42, 1077-1087.
21. Vonlanthen S., Heighway J., Tschan M.P., Borner M.M., Altermatt H.J., Kappeler A., Tobler A., Fey M.F., Thatcher N., Yarbrough W.G. & Betticher D.C. (1998) Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene 17, 2779-2785.